Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

Figure 3

Follistatin is detectable in serum in patients with NAFLD related HCC. Immune depleted serum samples from individuals with non-fibrotic NAFLD (N), NAFLD cirrhosis (Ci), and NAFLD cirrhosis with cancer (C) have been separated by SDS-PAGE and analysed by western blot. The majority of HCC patients had detectable levels of follistatin in their serum, as did one or two individuals with NAFLD cirrhosis and no cancer.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us